Abnormally activated signaling pathways as potential therapeutic targets, and diagnostic biomarkers in the management of small-cell lung cancers - A review

被引：0

作者：

Zhang, Lihai ^{[1
]}

Dai, Longxia ^{[1
]}

Xiao, Jian ^{[1
]}

He, Bixiu ^{[1
]}

机构：

[1] Cent South Univ, Xiangya Hosp, Dept Elderly Resp, Changsha 410008, Peoples R China

来源：

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH | 2021年 / 20卷 / 12期

关键词：

Small cell lung cancer (SCLC); Signaling pathway; Biomarker; Lung cancer; Chemotherapy; Radiotherapy; Immunotherapy;

D O I：

10.4314/tjpr.v20i12.30

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Small-cell lung cancer (SCLC) has relatively aggressive spread characteristics and a poor prognosis. Current treatment methods include surgery, chemotherapy, radiotherapy, and immunotherapy. However, the prognosis remains poor. This article summarizes the related signaling pathways and factors that may be used as therapeutic targets and early diagnostic biomarkers in the pathogenesis of SCLC. Furthermore, this study provides a theoretical reference for the clinical treatment of SCLC.

引用

页码：2675 / 2679

页数：5

共 47 条

[1] A narrative review of current and potential prognostic biomarkers for immunotherapy in small-cell lung cancer
Lim, Jeong Uk
Kang, Hye Seon
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (09)
[2] Small-cell lung cancer. Diagnostic and therapeutic recommendations of Polish Lung Cancer Group
Krzakowski, Maciej
Orlowski, Tadeusz
Roszkowski, Kazimierz
Reinfuss, Marian
Olszewski, Wlodzimierz
Ramlau, Rodryg
Kowalski, Dariusz
Konopa, Krzysztof
Jassem, Jacek
Jankowska, Renata
Kozielski, Jerzy
Wojtukiewicz, Marek
Drosik, Kazimierz
Koralewski, Piotr
ONCOLOGY IN CLINICAL PRACTICE, 2007, 3 (01): : 1 - 7
[3] Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
Zheng, Yue
Wang, Laduona
Yin, Limei
Yao, Zhuoran
Tong, Ruizhan
Xue, Jianxin
Lu, You
FRONTIERS IN ONCOLOGY, 2022, 12
[4] Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
Sutic, Maja
Vukic, Ana
Baranasic, Jurica
Foersti, Asta
Dzubur, Feda
Samarzija, Miroslav
Jakopovic, Marko
Brcic, Luka
Knezevic, Jelena
JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (11):
[5] Circulating endothelial cells and microparticles as diagnostic and prognostic biomarkers in small-cell lung cancer
Najjar, Fadi
Alammar, Moosheer
Al-Massarani, Ghassan
Almalla, Nissreen
Japawe, Abdulmunim
Ikhtiar, Adnan
LUNG CANCER, 2018, 124 : 23 - 30
[6] Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
di Meo, Nicola Antonio
Lasorsa, Francesco
Rutigliano, Monica
Loizzo, Davide
Ferro, Matteo
Stella, Alessandro
Bizzoca, Cinzia
Vincenti, Leonardo
Pandolfo, Savio Domenico
Autorino, Riccardo
Crocetto, Felice
Montanari, Emanuele
Spilotros, Marco
Battaglia, Michele
Ditonno, Pasquale
Lucarelli, Giuseppe
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
[7] Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers
Liang, Hongge
Xu, Yan
Zhao, Jing
Chen, Minjiang
Wang, Mengzhao
CANCER GENE THERAPY, 2024, 31 (05) : 652 - 666
[8] Long non-coding RNAs as potential therapeutic targets in non-small cell lung cancer (Review)
Tang, Peiyu
Sun, Dejuan
Xu, Wei
Li, Hua
Chen, Lixia
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2023, 52 (02)
[9] Unravelling key signaling pathways for the therapeutic targeting of non-small cell lung cancer
Chavan, Pavan Ramrao
Pandey, Ruchi
Patil, Baswant Malesh
Murti, Krishna
Kumar, Nitesh
EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 998
[10] Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer
Tokhanbigli, Samaneh
Haghi, Mehra
Dua, Kamal
Oliver, Brian Gregory George
CANCER DRUG RESISTANCE, 2024, 7

← 1 2 3 4 5 →